Encouraging results from Phase 1/2 study of mirdametinib in pediatric patients with low-grade glioma also to be presented in oral session at SNO – STAMFORD, Conn., (GLOBE NEWSWIRE) -- SpringWorks ...

This week Bobbi Conner talks with Dr. Anca Dumitriu about childhood cancer survivorship in S.C. Dr. Dumitriu is an Assistant ...

Routine blood draws during a doctor's visit can reveal disorders or diseases and as the number of patient caseloads inches ...

Saints veterans share their favorite must-eat foods when living in New Orleans on the latest Rookie Mistakes presented by ...

ABU DHABI, 9th November, 2024 (WAM) -- The 3rd Emirates Pediatric Bone Marrow Transplant (BMT) and Gene Therapy Congress began today in Abui Dhabi, highlighting the UAE's commitment to advancing ...

Erin Wright, M.D., is the new chairholder of the Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and ...

Drishti Ragoonanan to Southern Nevada’s only pediatric cancer and rare disease treatment center. As a board-certified pediatric hematology-oncology physician, Dr. Ragoonanan joins 18 other highly ...

Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~~ Increasing Momentum and Successful Reimbursement in the Adolescent and Young ...

The first hospital to open in Louisville’s West End in more than 150 years will welcome its first patient on Monday. Here's a ...

For the three months ended September 30, 2024, Syndax reported a net loss attributable to common stockholders of $84.1 million, or $0.98 per share, compared to a net loss attributable to common ...

Keating Toyota donated $15,000 to Texas Children's Hospital as part of its Steering Hope campaign, supporting pediatric ...

REFRaME-P1 is a registration-enabling study evaluating the efficacy and safety of luvelta in infants and children under 12 years of age with CBF/GLIS AML. This will be a global study, with the ...